Clinical Trial Update: Tadalafil for Treatment of Priapism in Men With Sickle Cell Anemia [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating tadalafil for treating priapism in men with sickle cell anemia was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Priapism
• Sickle Cell Disease

Drugs mentioned

• TADALAFIL (TADALAFIL)

Snippet

Sponsor: Johns Hopkins University | Conditions: Sickle Cell Anemia, Priapism | Phase 2 | Status: WITHDRAWN